tiprankstipranks
Advertisement
Advertisement
Lineage Cell Therapeutics provides update on COR1 program
PremiumThe FlyLineage Cell Therapeutics provides update on COR1 program
1M ago
Lineage Cell Shareholders Reaffirm Governance and Executive Pay
Premium
Company Announcements
Lineage Cell Shareholders Reaffirm Governance and Executive Pay
2M ago
Lineage Cell Therapeutics Highlights R&D Momentum Amid Losses
Premium
Company Announcements
Lineage Cell Therapeutics Highlights R&D Momentum Amid Losses
3M ago
Lineage Cell announces 36-month results from Phase 1/2a study of RG6501
PremiumThe FlyLineage Cell announces 36-month results from Phase 1/2a study of RG6501
3M ago
Lineage Cell Therapeutics initiated with a Buy at Canaccord
Premium
The Fly
Lineage Cell Therapeutics initiated with a Buy at Canaccord
4M ago
Lineage Cell Therapeutics announces formation of Scientific Advisory Board
Premium
The Fly
Lineage Cell Therapeutics announces formation of Scientific Advisory Board
4M ago
Lineage Cell Therapeutics Extends Runway Amid R&D Surge
PremiumCompany AnnouncementsLineage Cell Therapeutics Extends Runway Amid R&D Surge
5M ago
Regulatory Risks Loom for Lineage Cell Therapeutics as Legacy Pluripotent Cell Lines Face Potential Compliance Challenges
Premium
Company Announcements
Regulatory Risks Loom for Lineage Cell Therapeutics as Legacy Pluripotent Cell Lines Face Potential Compliance Challenges
5M ago
Lineage Cell Therapeutics reports Q4 EPS 0c vs (2c) last year
Premium
The Fly
Lineage Cell Therapeutics reports Q4 EPS 0c vs (2c) last year
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100